Inner ear vestibular hair cell (VHC) (VHC)

Inner ear vestibular cells are specialized sensory receptors located within the vestibular apparatus, specifically in the maculae of the utricle and saccule and the cristae ampullares of the semicircular canals. These cells, primarily Type I and Type II hair cells, are responsible for mechanotransduction, converting physical movements of the head and gravitational changes into electrical signals (StatPearls, 2023). This process is mediated by the deflection of stereocilia, which triggers the opening of mechanosensitive ion channels and subsequent neurotransmitter release to the vestibular nerve (NCBI, 2022). In clinical medicine, these cells are the primary site of pathology in disorders such as Meniere's disease and vestibular neuritis, where abnormal signaling results in vertigo and imbalance (NIDCD, 2023). Pharmacological management often involves vestibular suppressants like meclizine or scopolamine to dampen sensory input, or the use of betahistine to improve local microcirculation (DrugBank, 2024). In severe cases of Meniere's disease, these cells are targeted for chemical ablation using intratympanic gentamicin, which exploits the drug's selective ototoxicity to eliminate the source of vertigo (PubMed, 2021).

Other names

Vestibular hair cellsType I vestibular hair cellsType II vestibular hair cellsSemicircular canal hair cellsOtolith organ cellsVestibular sensory cells

Pharmacological agents interact with inner ear vestibular cells through several distinct pathways: aminoglycosides like gentamicin enter the hair cells through mechanotransduction channels and induce apoptosis to achieve chemical ablation (PubMed, 2021); betahistine acts as a weak H1 receptor agonist and a potent H3 receptor antagonist to increase blood flow in the inner ear (DrugBank, 2024); and vestibular suppressants like meclizine (an H1 antagonist) and scopolamine (a muscarinic antagonist) reduce the excitability of the vestibular system and its central projections (StatPearls, 2023).